MYASTHENIA GRAVIS
Clinical trials for MYASTHENIA GRAVIS explained in plain language.
Never miss a new study
Get alerted when new MYASTHENIA GRAVIS trials appear
Sign up with your email to follow new studies for MYASTHENIA GRAVIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Robot surgeons put to the test in delicate chest operations
Disease control OngoingThis study is testing a new, single-port robotic surgery system for removing parts of the lung (for cancer or benign disease) or the thymus gland. Researchers want to see if surgeons can complete these delicate chest operations using only this robot, without having to switch to t…
Matched conditions: MYASTHENIA GRAVIS
Phase: NA • Sponsor: Intuitive Surgical • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New drug aims to tame debilitating muscle disease
Disease control OngoingThis study is testing whether a drug called inebilizumab can help control myasthenia gravis, a disease that causes severe muscle weakness. About 238 adults with moderate to severe symptoms are comparing the drug to a placebo to see if it improves their ability to perform daily ac…
Matched conditions: MYASTHENIA GRAVIS
Phase: PHASE3 • Sponsor: Amgen • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Immune system 'Reset' tested for devastating brain and nerve diseases
Disease control OngoingThis study is testing a high-dose chemotherapy and stem cell transplant procedure for people with severe autoimmune diseases that attack the brain, spinal cord, or nerves, and who haven't responded to standard treatments. The goal is to 'reset' the patient's immune system to stop…
Matched conditions: MYASTHENIA GRAVIS
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New drug trial aims to control debilitating muscle disease
Disease control OngoingThis study is testing whether an intravenous drug called efgartigimod is effective and safe for adults with a specific, hard-to-treat form of generalized myasthenia Gravis (gMG). About 119 participants will be randomly assigned to receive either the drug or a placebo for part of …
Matched conditions: MYASTHENIA GRAVIS
Phase: PHASE3 • Sponsor: argenx • Aim: Disease control
Last updated Mar 05, 2026 13:59 UTC
-
New test aims to stop dangerous falls for people with Muscle-Weakening diseases
Diagnosis ENROLLING_BY_INVITATIONThis study aims to create and validate a simple set of physical tests to better predict the risk of falling for people with various nerve and muscle disorders. Researchers will test 108 patients with conditions like muscular dystrophy and ALS using tasks like standing up from a c…
Matched conditions: MYASTHENIA GRAVIS
Sponsor: LMU Klinikum • Aim: Diagnosis
Last updated Mar 20, 2026 14:47 UTC
-
Massive study tracks 1,200 patients to map the Real-World journey of a rare muscle disease
Knowledge-focused OngoingThis study aims to observe and document the real-world experience of people living with myasthenia gravis (MG) in China. It will follow about 1,200 patients of all ages to see how their symptoms, treatments, and quality of life change over time. The goal is to gather detailed inf…
Matched conditions: MYASTHENIA GRAVIS
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC
-
Massive study tracks Real-World results of MG treatments
Knowledge-focused ENROLLING_BY_INVITATIONThis registry aims to collect real-world information about how well myasthenia gravis treatments work and their safety over time. It will follow approximately 1,500 adults with myasthenia gravis who are starting new medications, tracking their experiences during regular doctor vi…
Matched conditions: MYASTHENIA GRAVIS
Sponsor: CorEvitas • Aim: Knowledge-focused
Last updated Mar 06, 2026 15:38 UTC